DermDefense, Inc. is a medical countermeasure company founded upon the conviction that United States warfighters and their allies should have access to the most advanced medicine and medical practices available. We have developed a proprietary topical treatment (SM-1997) for sulfur mustard gas injuries.
1917
The Germans first used it against the British during World War I during the battle of Flanders, near Ypres, Belgium, in 1917. It was used by the Allies in 1918 and by the Italians in Ethiopia in 1936.
1988
It has also been used recently in the Iran-Iraq War in 1984–1988 and by Iraq against its Kurdish minority in Halabjah in 1988.
2006
DermDefense team approached by Dr. John S. Graham PhD of the US Army Medical Reasearch Institute of Chemical Defense, Aberdeen Proving Ground, MD after hearing about the SM-1997 (Formulation developed by Sandra Chansler, Co-Founder of DermDefense, Inc.) and its ability to heal difficult wounds.
2008
Germany and Baltimore, MD
Sept 2009
Dr. Graham’s study, funded by the National Institute of Health and the Department of Defense, to find a treatment program for the Management of Cutaneous Sulfur Mustard Gas Injuries, resulted in this article published in Toxicology. [Kehe, K., & Thiermann, H. (2009). Clinical Picture of Sulfur Mustard Poisoning. Toxicology.]
Sept 2016
ISIS deployed sulfur mustard gas against US troops
July 2022
Sept 2022
The FDA Animal Rule allows the FDA to rely on the animal trials instead of costly human trials, greatly expediting the approval process and dramatically reducing development costs.
Oct 2022
2023 – 1st Quarter
2023 – 2nd Quarter
2024 – 1st Quarter
2024 – 4th Quarter
2025 – 3rd Quarter
2025 – 4th Quarter
Need new tagline here